These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32741873)

  • 1. [Manipulating Living Systems by Light].
    Sato M
    Yakugaku Zasshi; 2020; 140(8):993-1000. PubMed ID: 32741873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photoactivatable Cre-loxP recombination system for optogenetic genome engineering.
    Kawano F; Okazaki R; Yazawa M; Sato M
    Nat Chem Biol; 2016 Dec; 12(12):1059-1064. PubMed ID: 27723747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoactivatable CRISPR-Cas9 for optogenetic genome editing.
    Nihongaki Y; Kawano F; Nakajima T; Sato M
    Nat Biotechnol; 2015 Jul; 33(7):755-60. PubMed ID: 26076431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a tTA-dependent photoactivatable Cre recombinase knock-in mouse model for optogenetic genome engineering.
    Takao T; Hiraoka Y; Kawabe K; Yamada D; Ming L; Tanaka K; Sato M; Takarada T
    Biochem Biophys Res Commun; 2020 May; 526(1):213-217. PubMed ID: 32204914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Model for Optogenetic Genome Engineering.
    Takao T; Yamada D; Takarada T
    Acta Med Okayama; 2022 Feb; 76(1):1-5. PubMed ID: 35236992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
    Chen X; Chen Y; Xin H; Wan T; Ping Y
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
    Hoffmann MD; Mathony J; Upmeier Zu Belzen J; Harteveld Z; Aschenbrenner S; Stengl C; Grimm D; Correia BE; Eils R; Niopek D
    Nucleic Acids Res; 2021 Mar; 49(5):e29. PubMed ID: 33330940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9-based photoactivatable transcription systems to induce neuronal differentiation.
    Nihongaki Y; Furuhata Y; Otabe T; Hasegawa S; Yoshimoto K; Sato M
    Nat Methods; 2017 Oct; 14(10):963-966. PubMed ID: 28892089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.
    Polstein LR; Gersbach CA
    Nat Chem Biol; 2015 Mar; 11(3):198-200. PubMed ID: 25664691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Engineering for Stem Cell Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.
    Bubeck F; Hoffmann MD; Harteveld Z; Aschenbrenner S; Bietz A; Waldhauer MC; Börner K; Fakhiri J; Schmelas C; Dietz L; Grimm D; Correia BE; Eils R; Niopek D
    Nat Methods; 2018 Nov; 15(11):924-927. PubMed ID: 30377362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9-based photoactivatable transcription system.
    Nihongaki Y; Yamamoto S; Kawano F; Suzuki H; Sato M
    Chem Biol; 2015 Feb; 22(2):169-74. PubMed ID: 25619936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic regulation of embryo implantation in mice using photoactivatable CRISPR-Cas9.
    Takao T; Sato M; Maruyama T
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28579-28581. PubMed ID: 33139551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
    Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
    FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).
    Rodríguez-Rodríguez DR; Ramírez-Solís R; Garza-Elizondo MA; Garza-Rodríguez ML; Barrera-Saldaña HA
    Int J Mol Med; 2019 Apr; 43(4):1559-1574. PubMed ID: 30816503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for Light-Inducible Gene Editing and Transcription.
    Zhou XX; Zou X; Chung HK; Gao Y; Liu Y; Qi LS; Lin MZ
    ACS Chem Biol; 2018 Feb; 13(2):443-448. PubMed ID: 28938067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.